The nuclear hormone receptors (NRs) 1 are transcription factors that regulate target gene transcription in response to ligands such as steroid and thyroid hormones (T 3 ), retinoids, and vitamin D. The liganded NRs bind to their cognate hormone response elements, located in the promoter regions of target genes, and stimulate transcriptional activation by transmitting the signals to the basal transcriptional machinery via protein-protein interactions. NRs have been shown to interact directly with components of the basal transcription machinery such as TFIIB (1) (2) (3) and TBP (4) . In addition, the coactivators, which serve as bridging molecules between the NRs and basal transcriptional machinery, are also required to mediate ligandstimulated transactivation (5, 6) . Functional analysis of NRs has shown that there are two major activation domains. The N-terminal domain (AF-1) contains a ligand-independent activation function, whereas the extreme C-terminal region of the ligand-binding domain (AF-2) exhibits ligand-dependent transactivation (7) . The AF-2 region is conserved among NRs, and deletion or point mutations in this region can impair transcriptional activation without changing ligand-and DNA-binding affinities (8 -10) . Recent x-ray crystallographic studies of the ligand-binding domain (LBD) of NRs reveal that the ligand induces a major conformational change in the AF-2 region (11) (12) (13) , indicating that this region may play a critical role in mediating transactivation by a ligand-dependent interaction with coactivators. Several putative coactivators have been isolated and characterized, including SRC-1 (14 -17) , TIF2 (18)/GRIP1 (19) (referred to as TIF2 hereafter), TRAM-1 (20)/pCIP (21)/RAC3 (22)/ACTR (23)/AIB1 (24) (referred to as TRAM-1 hereafter), RIP140 (25) , TIF1 (26, 27) , p120 (28) , and CBP/p300 (15, 17, 29, 30) , and shown to interact with NRs in a ligand-dependent manner. As expected, these proteins have absent or diminished ability to interact with AF-2 mutants of NRs (16, 18 -20, 22, 23, 25, 26, 28) . Further, the receptor interaction sites in coactivators have been recently partially characterized. A consensus interaction motif, an helical leucine-charged residue-rich domain (LXXLL), was identified in many coactivators (21, 27, 31) . These coactivators, mutated in their LXXLL motif, could not maintain ligand-dependent interaction with NRs (21, 31) . Interestingly, some of the coactivators, including SRC-1, TIF2, TRAM-1, RIP140, p120, and CBP/p300 contain multiple LXXLL interaction motifs (20 -23, 31, 32) . For example, RIP140 has nine LXXLL motifs, each of which showed ligandand AF-2-dependent interaction with estrogen receptor (ER) (31) . In addition, nuclear hormone receptor corepressor, N-CoR (33) , has two nuclear receptor interaction sites (34) . However, little is known about the functional role of the multiple nuclear receptor interaction sites of coactivators or corepressors.
SRC-1 belongs to the 160-kDa protein subset of the nuclear receptor coactivator (NCoA) gene family that includes TIF2 and TRAM-1. The NCoA proteins are characterized by a basic helix-loop-helix/Per-AhR-Sim domain in the N-terminal, serine-threonine-rich sequence in central, and a glutamine (Q)-rich sequence in the C-terminal regions (15, (17) (18) (19) (20) (21) (22) (23) (24) . SRC-1 interacts with a variety of NRs in a ligand-dependent manner, and enhances ligand-stimulated transactivation in cotransfection assays (14, 20) . SRC-1 contains seven LXXLL motifs in its entire sequence. However, yeast two-hybrid analysis of the interaction between ER and the seven LXXLL motifs has shown that SRC-1 exhibits three functionally active LXXLL motifs in the central region (termed nuclear receptor binding domain-1, NBD-1) and another at the C terminus (termed NBD-2) out of the seven motifs (31) . The three LXXLL motifs in NBD-1 are also conserved among the other two NCoA proteins, TIF2 and TRAM-1. However, the LXXLL motif in C-terminal NBD-2 is specific for SRC-1, as the other two NCoA proteins do not contain a LXXLL motif in the homologous C-terminal region.
To understand the nature and role of the two NBDs of SRC-1, in vitro and in vivo interactions between TR and the two NBDs of SRC-1 were analyzed by several approaches in the present study. We also studied SRC-1E (15, 35, 36) , a natural SRC-1 isoform lacking NBD-2, to compare its coactivator function with that of SRC-1. Our findings suggest that DNA-induced, as well as ligand-induced, conformational change(s) of TR may influence the nature of its binding to SRC-1, and that the two NBDs of SRC-1 may play different roles in the regulation of ligand-dependent transactivation of TRs.
MATERIALS AND METHODS
Plasmids-GST fusion proteins containing cDNAs encoding the LBD (codon 174 -461) of the rat TR␤1 and its AF-2 mutant (E457A); LBD of mouse retinoid X receptor ␤ (RXR␤); LBD of human estrogen receptor (ER) and its AF-2 truncated mutant (ER⌬534); and full-length human RAR␤ were described previously (16) . GST-NBD-1 and GST-NBD-2 were constructed by inserting polymerase chain reaction-generated fragments of F-SRC-1 (16) (residues 595-780 and 1237-1440, respectively) into the GST plasmid (37) . Expression vectors for rat TR␤1 and its mutant, E457A (20) , and mouse RXR␤1 were based in pcDNA/AMP (Invitrogen). Human progesterone receptor-1 (PR-1) in pSG was kindly provided by Dr. P. Chambon, INSERM, Strasbourg, France. GAL4TR␤ encoding residues 1-94 of the GAL4 DNA binding sequence and 173-461 of the human TR␤1 LBD (a gift of Dr. A. Baniahmad, Justus-LiebigUniversität, Giessen, Germany) was described previously (38) . Fulllength SRC-1 (F-SRC-1) (16) was subcloned into pBK-CMV (Stratagene). To generate full-length SRC-1E in pBK-CMV, a 3Ј-fragment containing SRC-1E cDNA, which was cloned by a Far-Western library screening (see below), was fused to a 5Ј-fragment of F-SRC-1 in pBK-CMV. VP16-NBD-1, VP-16-NBD-2 and VP16-NBD-(1ϩ2) were constructed by inserting the polymerase chain reaction amplified fragments from F-SRC-1 (residues 595-780, 1237-1440, and 595-1440, respectively) into the EcoRI site of the activation domain of the VP16 (residues 409 -490) expression vector (39) (AASVVP16; a gift of Dr. S. M. Weissman, Yale School of Medicine, New Haven, CT). ⌬VP16 (residues 453-490) expression vector, whose transactivation function is eliminated (40) without disrupting its Kozak sequence, was created by EcoRV and PspA1 digestion of the VP16 vector, followed by Klenow fill-in and self-ligation. C-terminal deletion mutant of SRC-1, residues 1-780, was constructed by BamHI restriction enzyme digestion of F-SRC-1 in pBS-KS (Stratagene). N-terminal deletion mutant of SRC-1, residues 791-1440, was constructed by BamHI digestion and then self-ligation of the original clone of F-SRC-1 in pBS-SK. The luciferase (LUC) reporter constructs, the chick lysozyme (F2)-thymidine kinase (TK)-LUC, artificial direct repeat TRE, DR4-TK-LUC, and 1X upstream activating sequence (UAS)-TK-LUC in the PT109 vector were described previously (38, 41) . Mouse mammary tumor virus promoter (MMTV)-LUC (pMTV-LUC) was kindly provided by Dr. R. M. Evans, Salk Institute, La Jolla, CA.
In Vitro Translated Proteins and GST Pull-down Assay-Full-length and fragments of F-SRC-1 in pBS, and TR␤1, its AF-2 mutants and RXR␤ in pcDNA/AMP were transcribed and translated in rabbit reticulocyte lysates (Promega) with [ 35 S]methionine according to the manufacturer's instructions. The GST fusion protein pull-down assay was performed as described previously (16) . Briefly, the GST fusion proteins (ϳ2 g/lane) were bound to glutathione-Sepharose beads (Pharmacia). Similar amounts of loading fusion proteins of wild-type and cognate mutant receptors bound to the beads were used, as determined by Coomassie Blue staining/SDS-polyacrylamide gel electrophoresis analysis. The beads were resuspended in the binding buffer (20 mM Hepes (pH 7.7), 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 0.05% Nonidet P-40, 2 mM dithiothreitol, 10% glycerol), and incubated with 5 l of in vitro translated, 35 S-labeled proteins in the presence or absence of various ligands (1 M T 3 , 1 M estradiol, 1 M retinoic acid, or 1 M 9-cis-retinoic acid) for 1 h at room temperature. Beads were then washed with the binding buffer in the presence or absence of the ligands, resuspended in 30 l of 1ϫ SDS sample buffer, and analyzed by SDS-polyacrylamide gel electrophoresis and autoradiography.
GST Pull-down Assay in the Presence of DNA Response ElementsDeoxyribonucleotides containing 10 pmol of F2 or DR4 TRE or glucocorticoid hormone response element (GRE) were preincubated with 3 l of Either the full-length, N-terminal half containing NBD-1, or C-terminal half containing NBD-2 of SRC-1 were used in GST pull-down assays (see Fig. 2 ). C, schematic diagram of GST-NBD-1 and GST-NBD-2 fusion proteins. GST-NBD-1 and GST-NBD-2 contain residues 595-780 and 1237-1440 of SRC-1, respectively. The GST-NBD-1 and GST-NBD-2 were used in GST pull-down assays (see Figs. 3 and 5) and EMSA (see Figs. 6, 7, and 11). bHLH PAS, basic helix-loop-helix/PerAhR-Sim domain.
T 3 at 4°C for 1 h with occasional vortexing. After incubation, the beads were washed three times in the DNA-binding buffer in the presence or absence of 1 M T 3 , followed by SDS-polyacrylamide gel electrophoresis and autoradiography.
Electrophoretic Mobility Shift Assay (EMSA)-Deoxyribonucleotides containing F2, DR4, or UUU TRE (41, 42) were end-labeled with [␥-32 P]ATP by T4 polynucleotide kinase. Unlabeled in vitro translated receptor proteins, 20 ng of GST fusion proteins, and 50,000 cpm of oligonucleotide probe were mixed and incubated in the DNA-binding buffer and 1 g of shared salmon sperm DNA (Sigma) for 30 min at room temperature. Different amounts of control reticulocyte lysate were added to some samples so that the total volume of the reticulocyte lysate was constant. After incubation, samples were subjected to electrophoresis and analyzed by autoradiography.
Isolation of SRC-1E-The expression cDNA library screening by Far-Western blotting was performed as described previously (16, 20) . A human thyroid cDNA library (a gift of Dr. B. Rapoport, University of California, San Francisco) in ZAPII (Stratagene) was screened using 10 5 cpm/ml 32 P-labeled Escherichia coli-expressed LBD of rat TR␤1 in the presence of 1 M T 3 .
Transient Cotransfection Experiments-CV-1 cells were grown in Dulbecco's modified Eagle's medium, 10% fetal calf serum. The serum was stripped of hormones by constant mixing with 5% (w/v) AG1-X8 resin (Bio-Rad) and charcoal (Mallinckrodt) before ultrafiltration. CV-1 cells were transiently transfected using the calcium phosphate coprecipitation method in six-well plates with 1.7 g of reporter plasmid containing the F2, DR4 TRE-TK-LUC, or MMTV-LUC cDNA, 0.1 g of TR␤1 or PR-1, and various amounts of SRC-1 constructs, as detailed in the figure legends. Rous sarcoma virus (RSV)-␤-galactosidase plasmid was used as an internal control. In some samples, empty expression vectors (pcDNA/AMP or pBK-CMV) were added to equalize total transfected plasmid concentration. Alternatively, cotransfections were performed using 0.1 g of GAL4TR and 0.5 g of VP16 constructs with 1.7 g of reporter plasmid containing the 1X UAS-LUC cDNA. Cells were grown for 48 h in the absence or presence of hormones (10 Ϫ6 M T 3 or 10 Ϫ7 M progesterone), and harvested. Cell extracts then were analyzed for both luciferase and ␤-galactosidase activity in order to correct for transfection efficiency. The corrected luciferase activities of untreated samples were normalized to the luciferase activities of samples containing the vector alone in the absence of the ligand (1-fold basal). All transfection studies were repeated at least twice. The results shown are the mean Ϯ SD (n ϭ 3). Fig. 1A , SRC-1 contains two NBDs, one in its central (NBD-1) and an other in its C-terminal (NBD-2) regions. NBD-1 and NBD-2 contain three and one LXXLL motifs, respectively. To compare interaction properties of the two NBDs, we generated full-length, N-terminal half, and C-terminal half fragments of SRC-1 as 35 S-labeled in vitro translated proteins (Fig. 1B) , and used them in GST pull-down assays.
RESULTS

In Vitro Interaction Assay-As illustrated in
We first compared ligand-dependent interactions between full-length SRC-1 (1-1440) and various GST-NR fusion proteins. Full-length SRC-1 (1-1440) showed specific ligand-dependent interactions with TR, ER, RAR, and RXR GST fusion proteins ( Fig. 2A, lanes 2, 3, 6 , 7, and 10 -13). However, a TR AF-2 point mutant (E457A) (Fig. 2A, lanes 4 and 5) as well as an ER AF-2 truncation mutant (⌬534) (Fig. 2A, lanes 8 and 9) retained a ligand-dependent interaction with SRC-1, although the magnitude of binding to the AF-2 mutants was less than that of wild type. Based on similar data, we previously speculated the existence of interaction region(s) in NRs other than the AF-2 region (16) , and C-terminal half (residues 791-1440) (panel C) of SRC-1 with various GST-nuclear receptor fusion proteins linked to glutathione-agarose beads was analyzed by the pull-down assay in the presence or absence of 1 M cognate ligands (T 3 , estradiol, retinoic acid, or 9-cis-retinoic acid). Lane 1 corresponds to the input of in vitro translated SRC-1 fragments. The input lanes represent the 100% volume used in the pull-down assay. The GST fusion proteins tested were wild-type TR␤ (lanes 2 and 3), TR␤ (E457A) (lanes 4 and 5), wild-type ER (lanes 6 and 7), ER⌬534 (lanes 8 and 9), wild-type RAR␤ (lanes 10 and 11), and wild-type RXR␤ (lanes 12 and 13). Three independent sets of the same experiment were performed, and the results of a representative experiment are shown. which contains NBD-1, also showed a ligand-dependent interaction with GST nuclear receptor fusion proteins. In contrast, TR and ER AF-2 mutants showed negligible interaction (Fig. 2B) . Similar to the N-terminal fragment, the C-terminal fragment of SRC-1 containing NBD-2 also showed ligand-and AF-2-dependent interaction with GST nuclear receptor fusion proteins, except that this fragment of SRC-1 showed relatively less ligand-dependent interaction with GST-RAR fusion protein (Fig. 2C) . These GST pull-down experiments indicate that the overall conformation or subregion(s) of SRC-1 other than the NBDs may be also involved in ligand-dependent interaction with NRs. Other factors might include the precise sequence and number of the LXXLL motifs and receptor selectivity for interaction, as RAR could not significantly interact with NBD-2.
Next, as illustrated in Fig. 1C , we have expressed these two NBDs as GST fusion proteins, and a GST pull down experiment using 35 S-labeled in vitro translated TR, TR AF-2 mutant, E457A, and RXR was performed (Fig. 3) . Both GST-NBD-1 (residues 595-780) and GST-NBD-2 (residues 1237-1440) showed similar ligand-dependent interaction with TR and RXR (Fig. 3, A and B, lanes 1-3 and 7-9 ). However, a slight difference between the binding of NBD-1 and NBD-2 with the AF-2 mutant was noted. Compared with NBD-2, NBD-1 showed strong AF-2-dependent interaction with TR. In contrast, NBD-2 retained an interaction with the AF-2 mutant, E457A (Fig. 3, A and B, lanes 4 -6) . Interestingly, cotransfection experiments using the palindromic F2 (Fig. 4) and direct repeat TRE (DR4) reporters (data not shown) revealed that transcriptional activities of the AF-2 mutants of TR correlate well with the ability of NBD-1, rather than that of NBD-2, to interact with the AF-2 mutants. We conclude that, in solution in the absence of target DNA, both NBD-1 and NBD-2 interact efficiently with TR.
In Vitro Interaction Assay in the Presence of TRE-To determine whether DNA binding of TR could influence SRC-1 interaction with TR, GST pull-down experiments were carried out, using the two GST-NBDs and 35 S-labeled in vitro translated TR in the presence of oligonucleotides containing TREs and a negative control GRE. Based on our previous data of a Scatchard analysis of TR␤1 homodimer binding to TRE (43) , 2 the majority of input TR␤1 should be bound to TREs by incubation with an excess amount of oligonucleotides in this experiment. As shown in Fig. 5A , the ligand-dependent interaction between NBD-1 and TR was not affected by any DNA response element. In contrast, NBD-2 lost ligand-dependent interaction in the presence of F2 and DR4 TREs, but not a GRE (Fig. 5B) . Of note, the minor relative difference of the interaction of TR with NBD-1 or NBD-2 in the absence of DNAs, indicated between Figs. 3 and 5 and shown by the quantitative analysis, is due to the use of different binding buffer as detailed under "Materials and Methods."
We hypothesized that the difference of the interaction properties of TR and NBD-2 in the two GST pull-down assays is likely due to TR binding to DNA. To confirm this putative effect of DNA, an EMSA was performed using GST NBD-1 and GST NBD-2 fusion proteins (Fig. 6 ). TR␤1 forms homodimers and heterodimers with RXR on the inverted palindrome TRE, F2. Two TR/RXR bands were observed, as in vitro translated RXR␤ has two major translation products. Addition of T 3 decreased homodimer formation as noted previously (lane 5) (44) . Incubation of TR with NBD-1 produced a new ligand-dependent Ligand-dependent interaction of 35 S-labeled wild-type TR␤1 with GST-NBD-1 (panel A) or GST-NBD-2 (panel B) fusion proteins was analyzed by the GST pulldown assay in the presence of hormone response elements (F2, DR4, or GRE) employing the same DNA binding buffer used in EMSA. The input lanes represent 100% volume used in the pull-down assay. The interactions were quantified by determinations of the relative optical density compared with input using a PhosphorImager (Molecular Dynamics). Three independent sets of the same experiment were performed. The results of a representative autoradiography are shown with data depicted as mean Ϯ S.D. (n ϭ 3). Ⅺ, without ligand; f, with ligand.
TR⅐NBD-1 complex (lane 7)
. Incubation of TR-RXR heterodimers with NBD-1 produced a TR⅐RXR⅐NBD-1 complex observed as a supershift in the presence of T 3 (lane 14), but not in the presence of 9-cis-retinoic acid (lane 15). The mobility of TR⅐RXR⅐NBD-1 was slightly less than that of TR⅐NBD-1. In addition, RXR antibody could supershift the TR⅐RXR⅐NBD-1 complex (Fig. 7) , indicating that NBD-1 can interact with TR/ RXR heterodimer. As we reported previously (20) , an AF-2 mutant, E457A, failed to interact with NBD-1 (data not shown). In contrast, NBD-2 did not form any complexes with TR or TR/RXR heterodimers on F2 (Fig. 6, lanes 9, 17, and 18) . Even when we increased the amount of GST-NBD-2 (up to 100-fold), we could not see any interaction with TR (data not shown). Similar results were obtained when we used the direct repeat TRE, DR4 (data not shown). We also tested ER interaction with NBD-1 and NBD-2 on an estrogen-response element. Similar to TR, NBD-1, but not NBD-2, showed ligand-dependent interaction with ER on an estrogen-response element (data not shown).
In Vivo Interaction Assay-We next studied in vivo interactions between TR and the NBDs in the absence or presence of TRE by performing cotransfection experiments in CV-1 cells.
Using a mammalian two-hybrid assay in CV-1 cells, we tested whether interactions between the NBDs and TR occur in the absence of a TRE in vivo (Fig. 8) . The LBD of TR was fused to the GAL4 DNA binding domain, and the two NBDs were fused to the transactivation domain of VP16. In this system, when the GAL4 region binds to the UAS sequence, TR-mediated transactivation occurs. If a NBD interacts with TR, VP16-mediated transactivation also occurs. As shown in the schematic diagram in Fig. 8 , we used various VP16-NBD chimeric constructs, including VP16-NBD-1, VP16-NBD-2, and VP16-NBD-(1ϩ2), which contains both NBD-1 and NBD-2. Of note, SRC-1 also contains activation domains. In addition, interaction of NBDs with TR can block endogenous coactivator interaction with TR. Therefore, we also used ⌬VP16 constructs, which have lost the transactivation function of VP16 by virtue of an internal deletion (40) . In the absence of the VP16 construct and ligand, there was no transactivation. In the presence of ligand, GAL4TR-mediated transactivation occurred. Addition of VP16 alone did not show any significant increase. However, addition of each VP16-NBD further increased ligand-dependent transactivation, indicating that both NBD-1 and NBD-2 have ligand-dependent interactions with TR in vivo. Interestingly, when we used ⌬VP16 constructs, we observed that ⌬VP16-NBD-1 blocked the ligand-dependent GAL4TR-mediated transactivation, representing likely competition for endogenous coactivators. On the other hand, ⌬VP16-NBD-2 and ⌬VP16-NBD-(1ϩ2) still further stimulated ligand-dependent transactivation, suggesting that an endogenous transactivation domain may exist within NBD-2, as well as NBD-(1ϩ2). We conclude that both NBD-1 and NBD-2 mediate ligand-dependent interactions with TR in the absence of a TRE in vivo. In Vivo Interaction Assay in the Presence of TRE-To determine the nature of the NBD interactions with TR in the presence of a TRE in vivo, we cotransfected TR with the F2 or DR4 TRE reporter and the VP16 or ⌬VP16 constructs in CV-1 cells described above (Fig. 9) . Without the VP16 construct, TR-mediated transactivation occurs in the presence of ligand. Addi- FIG. 9 . In vivo interaction between TR and the two NBDs of SRC-1 on TREs. Interaction between TR␤ and VP16-NBDs in a modified mammalian two-hybrid assay using TRE reporters. Expression plasmids encoding TR␤1 (0.1 g) and either VP16 alone, VP16-NBD-1, VP16-NBD-2, or VP16-NBD-(1ϩ2) (0.5 g) were cotransfected with DR4 (panel A) or F2 (panel B) reporter plasmid (1.7 g) and the RSV-␤-galactosidase control vector (1 g) in CV-1 cells. ⌬VP16 constructs were also tested as control experiments. Cells were then treated with or without 10 Ϫ6 M T 3 for 48 h and analyzed for luciferase activity. Luciferase activity was normalized to ␤-galactosidase activity and then calculated as -fold luciferase activity, with 1-fold basal activity defined as the luciferase activity with pcDNA/AMP alone in the absence of the ligand. Three independent sets of the same experiment were performed, and the results shown are of a representative experiment and expressed as the mean Ϯ S.D. (n ϭ 3). The asterisk (*) denotes a significant difference from the luciferase value of the column that represents TR␤ and VP16 alone or TR␤ and ⌬VP16 alone in the presence of T 3 (p Ͻ 0.005).
FIG. 8. In vivo interaction between LBD of TR and the two NBDs of SRC-1.
Interaction between GAL4-TR and VP16-NBDs in a mammalian two-hybrid assay. Schematic diagram of VP16 or ⌬VP16 constructs used are shown on the left. Expression plasmids encoding GAL4-TR␤ (LBD of TR␤: residues 173-461) (0.1 g) and either VP16 alone, VP16-NBD-1, VP16-NBD-2, or VP16-NBD-(1ϩ2) (0.5 g) were cotransfected with UAS-TK-LUC reporter plasmid (1.7 g) and the RSV-␤-galactosidase control vector (1 g) in CV-1 cells. ⌬VP16 constructs, which lack the transactivation function of VP16 by virtue of an internal deletion, were also tested as control experiments. Cells then were treated with or without 10 Ϫ6 M T 3 for 48 h and analyzed for luciferase activity. Luciferase activity was normalized to ␤-galactosidase activity and then calculated as -fold luciferase activity, with 1-fold basal activity defined as the luciferase activity with GAL4-DBD alone in the absence of the ligand. Three independent sets of the same experiment were performed, and the results shown as a representative experiment and expressed as the mean Ϯ S.D. (n ϭ 3). The asterisk (*) denotes significant difference from the luciferase value of the column that represents GAL4-TR␤ and VP16 alone or GAL4-TR␤ and ⌬VP16 alone in the presence of T 3 (p Ͻ 0.005).
tion of VP16 alone did not show any significant change similar to the GAL4 system. The addition of VP16-NBD1 did not increase further ligand-dependent transactivation, and ⌬VP16-NBD-1 inhibited the TR-mediated transactivation; similar results as seen in the GAL4 experiment, indicating that NBD-1 interacts with TR in the presence of TREs. Both VP16-NBD-(1ϩ2) and ⌬VP16-NBD-(1ϩ2) increased transactivation similar to the GAL4 system. In contrast, addition of either VP16-NBD-2 or ⌬VP16-NBD-2 did not show any significant changes, suggesting that NBD-2 does not interact with TR in the presence of TREs. These in vivo binding studies indicate that NBD-1, but not NBD-2, has a ligand-dependent interaction with TR on TREs, consistent with the findings in the in vitro data.
Functional Properties of SRC-1 and SRC-1E-To investigate the physiological relevance of NBD-2, we employed one of the alternative splicing variants of SRC-1, called SRC-1E (15, 35, 36) . SRC-1E lacks 55 amino acids of the C-terminal end of SRC-1, including the consensus LXXLL motif in NBD-2 and has a unique 14 amino acids (1399 amino acids in total). We have cloned the cDNA fragment of SRC-1E, encoding an open reading frame corresponding to amino acid residues 580 -1399 by Far-Western based library screening using TR as a probe. To compare the coactivator activities of SRC-1 and SRC-1E, cotransfection studies in CV-1 cells were performed with TR or PR on TRE (F2 or DR4)-TK-LUC or MMTV-LUC reporter, respectively. As shown in Fig. 10 , cotransfection of SRC-1 or SRC-1E similarly enhances ligand-mediated transactivation of TR as well as PR on these reporters, indicating again the crucial role of NBD-1 for ligand-mediated transactivation. Of note, without cotransfection of SRC-1 or SRC-1E, ligand-induced activation of TR or PR is less than that of data shown in Fig. 9 and reported elsewhere (22) , which is probably due to an increasing amount of total transfected DNA and decreasing ratio of transfected receptor and reporter DNAs.
NBD-1 Interaction with TR Using Active or Inactive DR4, TRE-Finally, we employed an inactive DR4, called UUU, for EMSA (42) . UUU contains a DR4 arrangement with replacement of 4 base pairs of the downstream flanking and spacer sequences with 4 base pairs of the upstream sequence (U) (42) . Although TR can form a heterodimer with RXR on UUU by EMSA, similar to the original DR4, previous transfection studies showed preserved basal repression but defective ligand-dependent transactivation by TR on this element (42) , indicating that TR may not be able to interact with coactivators in this setting. As shown in Fig. 11 , GST-NBD-1 exhibited a ligand-dependent interaction with the TR⅐RXR complex on an active TRE, DR4 (Fig. 11A, lane 10) . However, GST-NBD-1 did not show any ligand-dependent interaction with the TR⅐RXR complex on an inactive TRE, UUU (Fig. 11B, lane 10) . Even when we increased the amount of GST-NBD-1 (up to 100-fold), we could not see any interaction with the TR⅐RXR complex (data not shown).
DISCUSSION
The data presented here suggest an important role of the conformational changes of NRs induced by DNA binding as well as ligand binding for their interactions with coactivators. In the present study, we showed different interaction properties among full-length, N-and C-terminal fragments of SRC-1 with NRs. We then characterized two NBDs, NBD-1 and NBD-2, located at the central and C-terminal regions of SRC-1, respectively. We found that NBD-1, but not NBD-2, could interact with TR in the presence of TREs. In addition NBD-1 failed to interact with TR on a transcriptionally inactive TRE.
The LXXLL motifs in coactivators are critical for ligand-and AF-2-dependent interaction with NRs (21, 31). However, there are several lines of evidence indicating that AF-2 is not the only region that mediates ligand-dependent interaction with NRs. sequence (45) . Second, recent studies using a helix 3 mutant in the LBD of ER or TR demonstrate that the helix 3 as well as the AF-2 (helix 12) are important for ligand-dependent interaction with SRC-1 and TRAM-1 (20, 46) . Third, SRC-1 is able to enhance the estrogen-stimulated transcriptional activity of an AF-2 mutant of ER (47) . We have shown here that the fulllength, but not fragments of, SRC-1 retained ligand-dependent interaction with AF-2 mutants. Although the possibility that all LXXLL motifs are needed to interact with AF-2 mutants cannot be ruled out, the overall conformation of SRC-1 or subregion(s) other than the LXXLL motifs in SRC-1 may also participate in ligand-dependent interaction with NRs.
Both in vitro and in vivo results demonstrate the different interaction properties of the two NBDs in SRC-1. Thus, both NBD-1 and NBD-2 can interact independently with TR in a ligand-dependent manner in solution. However, when TR binds to a TRE, NBD-1, but not NBD-2, exhibits ligand-dependent interaction with TR. Even though each interaction site contains LXXLL sequences, each site has a different affinity and selectivity for NRs (21, 31). Our observation regarding the different properties of NBD-1 and NBD-2 are consistent with these findings. We and others previously reported evidence that conformational changes of TR occur after DNA binding (42, 48, 49) . Thus, NBD-2 may no longer be accessible to TR due to a DNA-induced conformational change.
TR bound to a TRE can mediate transactivation. Transcriptional activities of the AF-2 mutants of TR correlate well with the ability of NBD-1 to interact with the AF-2 mutants, but not with NBD-2. In addition, although NBD-1 is conserved among the 160-kDa proteins of the NCoA family such as SRC-1, TIF2, and TRAM-1, NBD-2 is not. These data then suggest that NBD-1 plays a predominant role in the interaction of SRC-1 with DNAbound TR. In fact, transfection studies using SRC-1 mutated in one or combination of the three LXXLL motifs in NBD-1 have shown that the mutants decrease or fail to enhance ligand-induced RAR-or ER-mediated transactivation (21, 31) .
Arguing against our hypothesis that NBD-1 may be more important for coactivator function than NBD-2 is the observation by Oñ ate et al. (14) that NBD-2 of SRC-1 blocks the ligand-induced PR-and TR-mediated transactivation in cotransfection experiments. Using an in vitro transcription system, their group also recently has shown that NBD-2, but not NBD-1, inhibits the progesterone-stimulated PR-driven transcription (50) . In contrast, we clearly showed that the expression of NBD-1 (⌬VP16 NBD-1) can inhibit the ligand-stimulated transactivation of TR. Moreover, a natural isoform of SRC-1, SRC-1E, which lacks the LXXLL motif in NBD-2, exhibited enhanced ligand-stimulated transactivation of TR and PR on the cognate response elements. Recent studies from other laboratories indicated that SRC-1E is a more potent activator compared with SRC-1 (35, 36) . We did not observe this difference. The reason(s) for the discrepancy between the results of our laboratory and those of Hayashi et al. (35) and Kalkhoven et al. (36) is not known. Further studies will be necessary to investigate the role of the LXXLL motif in NBD-2.
Kurokawa et al. (51) previously compared the interaction properties of nuclear hormone receptor corespressor, N-CoR, with RAR/RXR heterodimers among functionally active DR5 and inactive DR1 DNA response elements. They showed that retinoic acid dissociates nuclear hormone receptor corespressor from the RAR/RXR heterodimer complex on DR5, but not on DR1. They concluded that DNA response elements can allosterically regulate RAR-corepressor interaction. Similar to this phenomenon, we show that a TRE regulates the TR-coactivator interaction. NBD-1 interacts with TR on a transcriptionally active TRE, DR4. In contrast, NBD-1 fails to interact with TR on an inactive TRE, UUU, in EMSA. This finding is also consistent with a crucial role of NBD-1 in TR action.
The two NBDs in SRC-1, which contain multiple LXXLL motifs and are present in several coactivators, may allow interaction with multiple NRs via multiple sites. Recent findings revealed that liganded NR may form multiple complexes with NCoAs, CBP/p300 and P/CAF (20, 23, 50) . NRs also have been shown to interact directly with many other cofactors such as RIP 140, TIF1, Trip 1-11, and factors associated with the basal transcriptional machinery such as TBP and TFIIB. Although NRs, SRC-1, CBP/p300, and P/CAF can interact each other (15, 23, 50, 52), we wonder whether one molecule of NR bound to its DNA-response element can contact so many other proteins simultaneously. However, several NRs may interact with a coactivator via multiple interaction motifs, which then may, in turn, allow these NRs to contact additional cofactors. A different type of NR may also interact with a particular coactivator through the multiple interaction sites and thus possibly serve as a mediator of cross-talk among NRs.
In summary, we have characterized two NBDs in SRC-1. DNA-induced, as well as ligand-induced, conformational change(s) of TR may influence the nature of its binding to SRC-1. Thus, the two NBDs of SRC-1 may play different roles in the regulation of ligand-dependent transactivation of TRs.
